Aptus Capital Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Sell
2,483
-636
-20% -$61K ﹤0.01% 1045
2026
Q1
$323K Sell
3,119
-587
-16% -$66.6K ﹤0.01% 849
2025
Q4
$374K Sell
3,706
-6,802
-65% -$738K ﹤0.01% 821
2025
Q3
$1.3M Buy
10,508
+854
+9% +$106K 0.01% 503
2025
Q2
$1.16M Buy
9,654
+1,933
+25% +$258K 0.01% 501
2025
Q1
$1.14M Buy
7,721
+2,788
+57% +$426K 0.01% 488
2024
Q4
$801K Buy
+4,933
New +$807K 0.01% 532

Other funds holding CLX

Aptus Capital Advisors's CLX Position: Q2 2026 in Review

Aptus Capital Advisors reduced its Clorox (CLX) stake by 20% in Q2 2026, selling an estimated $61K and leaving 2,483 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1045.

Aptus Capital Advisors first reported a position in CLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.3M in Q3 2025. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Aptus Capital Advisors held 2,483 shares of Clorox worth $237K as of Q2 2026.
  • Aptus Capital Advisors sold 636 Clorox shares in Q2 2026, an estimated $61K.
  • Clorox made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1045 holding.
  • Aptus Capital Advisors first reported a position in Clorox in Q4 2024 and has held it in 7 quarters since.
  • Aptus Capital Advisors's Clorox position peaked at $1.3M in Q3 2025.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.